Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations

Y. Niazi, H. Thomsen, B. Smolkova, L. Vodickova, S. Vodenkova, M. Kroupa, V. Vymetalkova, A. Kazimirova, M. Barancokova, K. Volkovova, M. Staruchova, P. Hoffmann, MM. Nöthen, M. Dusinska, L. Musak, P. Vodicka, K. Hemminki, A. Försti

. 2021 ; 12 (-) : 691947. [pub] 20210616

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21024555

DNA damage and unrepaired or insufficiently repaired DNA double-strand breaks as well as telomere shortening contribute to the formation of structural chromosomal aberrations (CAs). Non-specific CAs have been used in the monitoring of individuals exposed to potential carcinogenic chemicals and radiation. The frequency of CAs in peripheral blood lymphocytes (PBLs) has been associated with cancer risk and the association has also been found in incident cancer patients. CAs include chromosome-type aberrations (CSAs) and chromatid-type aberrations (CTAs) and their sum CAtot. In the present study, we used data from our published genome-wide association studies (GWASs) and extracted the results for 153 DNA repair genes for 607 persons who had occupational exposure to diverse harmful substances/radiation and/or personal exposure to tobacco smoking. The analyses were conducted using linear and logistic regression models to study the association of DNA repair gene polymorphisms with CAs. Considering an arbitrary cutoff level of 5 × 10-3, 14 loci passed the threshold, and included 7 repair pathways for CTA, 4 for CSA, and 3 for CAtot; 10 SNPs were eQTLs influencing the expression of the target repair gene. For the base excision repair pathway, the implicated genes PARP1 and PARP2 encode poly(ADP-ribosyl) transferases with multiple regulatory functions. PARP1 and PARP2 have an important role in maintaining genome stability through diverse mechanisms. Other candidate genes with known roles for CSAs included GTF2H (general transcription factor IIH subunits 4 and 5), Fanconi anemia pathway genes, and PMS2, a mismatch repair gene. The present results suggest pathways with mechanistic rationale for the formation of CAs and emphasize the need to further develop techniques for measuring individual sensitivity to genotoxic exposure.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21024555
003      
CZ-PrNML
005      
20211013133900.0
007      
ta
008      
211006s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fgene.2021.691947 $2 doi
035    __
$a (PubMed)34220964
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Niazi, Yasmeen $u Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
245    10
$a DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations / $c Y. Niazi, H. Thomsen, B. Smolkova, L. Vodickova, S. Vodenkova, M. Kroupa, V. Vymetalkova, A. Kazimirova, M. Barancokova, K. Volkovova, M. Staruchova, P. Hoffmann, MM. Nöthen, M. Dusinska, L. Musak, P. Vodicka, K. Hemminki, A. Försti
520    9_
$a DNA damage and unrepaired or insufficiently repaired DNA double-strand breaks as well as telomere shortening contribute to the formation of structural chromosomal aberrations (CAs). Non-specific CAs have been used in the monitoring of individuals exposed to potential carcinogenic chemicals and radiation. The frequency of CAs in peripheral blood lymphocytes (PBLs) has been associated with cancer risk and the association has also been found in incident cancer patients. CAs include chromosome-type aberrations (CSAs) and chromatid-type aberrations (CTAs) and their sum CAtot. In the present study, we used data from our published genome-wide association studies (GWASs) and extracted the results for 153 DNA repair genes for 607 persons who had occupational exposure to diverse harmful substances/radiation and/or personal exposure to tobacco smoking. The analyses were conducted using linear and logistic regression models to study the association of DNA repair gene polymorphisms with CAs. Considering an arbitrary cutoff level of 5 × 10-3, 14 loci passed the threshold, and included 7 repair pathways for CTA, 4 for CSA, and 3 for CAtot; 10 SNPs were eQTLs influencing the expression of the target repair gene. For the base excision repair pathway, the implicated genes PARP1 and PARP2 encode poly(ADP-ribosyl) transferases with multiple regulatory functions. PARP1 and PARP2 have an important role in maintaining genome stability through diverse mechanisms. Other candidate genes with known roles for CSAs included GTF2H (general transcription factor IIH subunits 4 and 5), Fanconi anemia pathway genes, and PMS2, a mismatch repair gene. The present results suggest pathways with mechanistic rationale for the formation of CAs and emphasize the need to further develop techniques for measuring individual sensitivity to genotoxic exposure.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Thomsen, Hauke $u Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u GeneWerk GmbH, Heidelberg, Germany
700    1_
$a Smolkova, Bozena $u Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia
700    1_
$a Vodickova, Ludmila $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia $u First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia
700    1_
$a Vodenkova, Sona $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia
700    1_
$a Kroupa, Michal $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia $u First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia
700    1_
$a Kazimirova, Alena $u Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Barancokova, Magdalena $u Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Volkovova, Katarina $u Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Staruchova, Marta $u Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia
700    1_
$a Hoffmann, Per $u Institute of Human Genetics, School of Medicine and University Hospital Bonn, University of Bonn, Bonn, Germany $u Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland
700    1_
$a Nöthen, Markus M $u Institute of Human Genetics, School of Medicine and University Hospital Bonn, University of Bonn, Bonn, Germany
700    1_
$a Dusinska, Maria $u Health Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway
700    1_
$a Musak, Ludovit $u Jessenius Faculty of Medicine, Biomedical Center Martin, Comenius University in Bratislava, Bratislava, Slovakia
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia $u First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia
700    1_
$a Hemminki, Kari $u Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia $u Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany
700    1_
$a Försti, Asta $u Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany $u Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany $u Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany
773    0_
$w MED00184539 $t Frontiers in genetics $x 1664-8021 $g Roč. 12, č. - (2021), s. 691947
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34220964 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20211006 $b ABA008
991    __
$a 20211013133857 $b ABA008
999    __
$a ind $b bmc $g 1708369 $s 1145052
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 691947 $e 20210616 $i 1664-8021 $m Frontiers in genetics $n Front Genet $x MED00184539
LZP    __
$a Pubmed-20211006

Find record

Citation metrics

Archiving options